BidaskClub upgraded shares of HealthEquity, Inc. (NASDAQ:HQY) from a strong sell rating to a sell rating in a report released on Friday morning.

A number of other equities research analysts have also commented on HQY. Cantor Fitzgerald upped their price objective on shares of HealthEquity from $50.00 to $55.00 and gave the company an overweight rating in a research note on Wednesday, June 7th. Oppenheimer Holdings, Inc. reaffirmed an outperform rating and issued a $61.00 price objective (up from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Zacks Investment Research raised shares of HealthEquity from a hold rating to a buy rating and set a $54.00 price objective on the stock in a research note on Wednesday, July 12th. Chardan Capital upped their price objective on shares of HealthEquity from $53.00 to $57.00 and gave the company a buy rating in a research note on Wednesday, June 7th. Finally, TheStreet raised shares of HealthEquity from a c rating to a b rating in a research note on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus price target of $56.50.

Shares of HealthEquity (NASDAQ HQY) traded down 1.53% during trading on Friday, reaching $45.12. 1,500,491 shares of the company’s stock were exchanged. HealthEquity has a 52-week low of $30.34 and a 52-week high of $54.95. The stock has a market cap of $2.71 billion, a PE ratio of 84.81 and a beta of 1.75. The stock’s 50 day moving average price is $44.62 and its 200-day moving average price is $45.93.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The firm had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. During the same period in the prior year, the company posted $0.16 EPS. The company’s revenue was up 28.7% on a year-over-year basis. On average, equities research analysts forecast that HealthEquity will post $0.71 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/09/16/healthequity-inc-hqy-upgraded-to-sell-by-bidaskclub.html.

In related news, Director Frank Medici sold 537,102 shares of the stock in a transaction on Friday, July 14th. The shares were sold at an average price of $51.24, for a total transaction of $27,521,106.48. Following the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at $326,962.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Ashley Dreier sold 10,000 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total transaction of $455,000.00. Following the transaction, the vice president now directly owns 15,652 shares in the company, valued at $712,166. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,976,064 shares of company stock worth $100,665,521. Insiders own 29.00% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in HealthEquity by 6.2% during the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after acquiring an additional 240,136 shares in the last quarter. Paloma Partners Management Co bought a new position in HealthEquity during the first quarter worth $503,000. First Trust Advisors LP boosted its stake in HealthEquity by 17.0% during the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after acquiring an additional 13,676 shares in the last quarter. Royce & Associates LP boosted its stake in HealthEquity by 18.0% during the second quarter. Royce & Associates LP now owns 139,200 shares of the company’s stock worth $6,936,000 after acquiring an additional 21,200 shares in the last quarter. Finally, Teacher Retirement System of Texas bought a new position in HealthEquity during the second quarter worth $200,000. 91.86% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.